Human Anti-Human Complement C9 Monoclonal Antibody (CTJS-106)(Cat#: CTA-062)
This product is an unconjugated anti-Human Complement C9 Monoclonal antibody (CTJS-106) generated from the Human. The antibody can be used for WB; FC; IA; IF; IHC.
Summary
Related Products & Services
Specifications
| Clonality |
Monoclonal |
| Clone |
CTJS-106 |
| Host Animal |
Human |
| Isotype |
IgG1 |
| Immunogen |
Neoepitope on the 61 kDa complement component C9, integrated in the terminal complement complex (TCC) |
| Species Reactivity |
Human |
| Applications |
WB; FC; IA; IF; IHC |
| Application Notes |
WB: 1:100-1:2000
FC: 1:10-1:1000
IF: 1:10-1:500
IHC: 1:10-1:500
The optimal working dilutions should be determined by the end user. |
| Specificity |
This antibody reacts with Human complement C9. |
| Purity |
≥95% as determined by SDS-PAGE |
| Format |
Liquid |
| Size |
25; 100 µg |
| Storage |
4°C |
| Type |
Primary Antibody |
Target
| Target Name |
C9 |
| Alternative Names |
Complement Component 9; Complement C9 ; ARMD15; C9D |
| Gene ID |
735 |
| UniProt ID |
P02748 |
Information
| Introduction |
Complement component 9 is a protein involved in the complement system, which is part of the innate immune system. It is a member of the complement membrane attack complex (MAC) and induces pores on cell membranes, causing lysis. There are 10-16 molecules of C9 in a single membrane attack complex (MAC), along with one of each of the complement components C5b, C6, C7 and C8. |
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
